GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

NRC · Mar 31, 2026

NRC HEALTH. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001437749-26-015083General Corporate
Capex intensity8thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

5.27% · OPTIONAL · VALID

Operating cash generation31thOwn-history percentile · N=13
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

20.63% · OPTIONAL · VALID

Revenue growth100thOwn-history percentile · N=9
Evidence method

Yoy · gp.fundamentals.revenue

3.73% · CORE · VALID

Operating margin8thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.operating_margin

16.00% · CORE · VALID

SBC intensity100thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

4.62% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
7.79%
Current
5.27%
Delta
-2.52%
Cash Generation Increased
Previous
19.25%
Current
20.63%
Delta
1.38%
Growth Increased
Previous
-3.96%
Current
3.73%
Delta
7.70%
Profitability Decreased
Previous
16.44%
Current
16.00%
Delta
-0.44%
Sbc Intensity Increased
Previous
2.41%
Current
4.62%
Delta
2.21%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.